Revenues

+83.6% (from $17,417K in Q1 2024 to $31,975K in Q1 2025)

Revenues surged significantly as Q1 2025 saw a strong boost in sales compared to Q1 2024. This dramatic increase indicates a major shift in market penetration or new contract wins—possibly reflecting expanded operations or portfolio enhancements that build on the previous period’s lower base value. " "

Gross Profit

+20.3% (from $13,088K in Q1 2024 to $15,738K in Q1 2025)

Gross profit improved in line with the revenue growth but at a lower percentage, suggesting that while higher sales drove more profit, the underlying cost of goods sold increased at a relatively faster pace compared to product pricing improvements. " "

Total Operating Expenses

~+34% (from $19,947K in Q1 2024 to $26,752K in Q1 2025)

Operating expenses increased substantially, driven mainly by an over 120% jump in general and administrative expenses (from $5,957K to $13,137K). This indicates significant investments in administrative capacity or operational scaling relative to the lower expenses in the previous period. " "

Net Loss

+61.4% (from $7,873K in Q1 2024 to $12,689K in Q1 2025)

Net loss widened sharply as the cost increases, particularly from the steep rise in operating expenses, outpaced the improvements in gross profit. Although revenues were much higher, the margin compression and elevated overhead costs (especially G&A) contributed to a much larger net loss compared to the previous quarter. " "

Total Assets

~+6.2% (from $133,449K in Q1 2024 to $141,988K in Q1 2025)

Total assets grew modestly, reflecting cumulative growth and continued investment in the business. The increase may be attributed to the accrual of additional receivables and capital assets as a consequence of expanding operations from the previous period’s foundation. " " " "

Stockholders’ Equity

~+24.4% (from $31,799K in Q1 2024 to $39,531K in Q1 2025)

Stockholders’ equity rose significantly despite wider net losses, likely due to new equity infusion such as additional share issuances combined with retained capital from earlier periods. This contrasts with the previous period where lower equity levels were observed and demonstrates a strategic capital restructuring or enhanced investor confidence. " " " "

Cash and Cash Equivalents

Modest increase (from $18,459K in Q4 2024 to $20,224K in Q1 2025)

Cash improved slightly in Q1 2025, suggesting better liquidity management or favorable financing/operational cash flow relative to the end of the previous quarter. This modest increase indicates that despite higher operational outlays, the company managed to generate or retain additional cash. " "